Targeted treatment for severe drug allergy
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial tests a targeted medicine for a severe drug reaction called DRESS, which can cause rash, fever, and organ problems. The goal is to see if the treatment helps control the reaction and improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with DRESS syndrome, a severe reaction to a medicine, with a rash and fever.
- You have at least one organ affected, like your liver, kidneys, lungs, or lymph nodes.
- You have a high number of a type of white blood cell called eosinophils in your blood.
- You are willing to stop taking the medicine that caused the reaction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how certain immune cells (eosinophils) behave during severe drug reactions like DRESS and during milder drug rashes. It may help doctors understand what drives organ damage and improve how these reactions are managed.
This trial compares two medicines—cyclosporine and steroid treatment—for a rare, serious drug reaction called DRESS. It aims to see which treatment controls the illness more safely and effectively.
This study collects skin and blood samples from adults who have a serious rash caused by medicines. The goal is to better understand these reactions and how to diagnose them sooner and more accurately.
This study is for people with severe eosinophilic asthma who are about to start a medicine called Benralizumab (Fasenra). It will observe how the medicine works in real life, and requires you to answer some questions about your asthma every week and month.
This trial tests a drug called daratumumab, which is usually used for certain cancers, to see if it can help people with a rare but severe skin condition caused by a medicine. The condition causes the top layer of skin to blister and peel off. The study aims to stop the skin from peeling further.
This study tests whether benralizumab, a biologic medicine, works well in real-world settings for people with severe asthma caused by an allergic reaction to a common mold called Aspergillus. You may qualify if you have hard-to-control asthma despite strong medications and recent asthma flare-ups.
Hear when a new DRESS Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.